The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation

FEMS Immunol Med Microbiol. 1999 Nov;26(2):131-5. doi: 10.1111/j.1574-695X.1999.tb01380.x.

Abstract

Four common Lactobacillus strains were screened for their effects on proliferation of mouse splenic lymphocytes. Mice received perorally 10(9) viable bacteria kg(-1) body weight for 7 days. Lactobacillus acidophilus treatment enhanced ex vivo basal proliferation (by 43%) and B-cell response at suboptimal and optimal concentrations of lipopolysaccharide (LPS) (by 27-28%). Conversely, Lactobacillus casei, Lactobacillus gasseri and Lactobacillus rhamnosus inhibited both basal proliferation (by 14-51%) and mitogen-stimulated lymphoproliferation, particularly at supra-optimal concentrations of concanavalin A (by 43-68%) and LPS (by 23-62%). Therefore, these Lactobacillus strains demonstrate strain-specific effects on B- and T-cells and may also alter the splenocyte sensitivity to the cytotoxic effects of mitogens.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / pharmacology*
  • Administration, Oral
  • Animals
  • Cell Division
  • Concanavalin A / pharmacology
  • Lacticaseibacillus casei
  • Lactobacillus acidophilus
  • Lactobacillus*
  • Lipopolysaccharides / pharmacology
  • Lymphocytes / cytology*
  • Male
  • Mice
  • Mitogens / pharmacology
  • Probiotics / administration & dosage
  • Probiotics / pharmacology*
  • Species Specificity
  • Spleen / cytology*

Substances

  • Adjuvants, Immunologic
  • Lipopolysaccharides
  • Mitogens
  • Concanavalin A